搜索到 1000 条关于 s78텔레그램darknessDB※II토토디비문의○ㄱ 的文章

青春期女孩,这些营养问题会粉碎你的美丽(下)

2021.08.13 青春期女孩,这些营养问题会粉碎你的美丽(下)

小姐姐或小哥哥「聊聊天」了:生酮饮食素食/蛋奶素轻断食瘦身汤代餐粉/棒增肌餐减肥 ......作为营养师,我已经反复嚷嚷过三点:●流行的,不一定是对的,更不一定是安全的!●明星
第一次做肠镜,需要做好哪些准备?

2020.11.19 第一次做肠镜,需要做好哪些准备?

,总觉得它又痛苦,又尴尬。为什么有些人的肠镜检查更顺利?不管是出于什么原因,要想做一个相对满意的肠镜检查,了解以下的内容会对您有帮助。大肠癌的高危因素:大便潜血检查阳性。一级亲属(比如父母,兄弟姐妹等)有大肠癌病史。直系亲属中有结直肠息肉家族史者。本人

2015.06.23 固体制剂溶出度试验技术与化学药物稳定性研究技术

技术》与《化学药物稳定性研究技术》请注明地点:杭州成都 单位名称地址邮编联系人电话/手机 

2015.07.30 波恩大学 Uni Bonn

to be one of Germany's and indeed Europe's most important institutes... of the world's leading research based Universities and therefore
还在等?眼袋是不会自动消失的

2020.09.21 还在等?眼袋是不会自动消失的

有眼病的人能否做眼袋手术?眼袋手术的适应症很广,但也有些禁忌症,例如: 有先天弱视、慢性结膜炎、红眼病、急性感染等眼科疾患者; 有出血倾向疾病和高血压病者; 心、肺、肝、肾等重要器官的活动性和进行性疾病者; 尚未控制的糖尿病和传染性疾病者; 月经期、孕妇或妊娠期女性等。如有这些情况,都不建议进行
舒尼替尼未能改善肝细胞癌患者的总生存期

2013.12.26 舒尼替尼未能改善肝细胞癌患者的总生存期

肝细胞癌患者的总生存期比较研究要点: 本试验旨在评价舒尼替尼在晚期肝细胞癌中的疗效; 研究结果表明,舒尼替尼未能改善肝细胞癌患者的总生存期,与舒尼替尼相关的严重不良事件更高。舒尼替尼在肝细胞癌患者中的疗效是否优于或相当于索拉替尼目前还没有结论。为此,来自国立台湾大学医学院附属医院的郑安理教授等人做了一项开放的II ...

2013.09.04 功能性二尖瓣反流增NSTSEACS房颤风险

西班牙一项研究表明,非ST段抬高型急性冠脉综合征(NSTSEACS)后功能性二尖瓣反流常见,并可对预后产生不良影响。论文8月19日在线发表于《心脏》(Heart)。\r\n  此项前瞻性队列研究共纳入237例首次NSTSEACS后出院患者。受试者NYHA分级1~II,男性占74%,平均年龄66.1%。所有患者均在入院第一周接受心电图检查,并接受中位6.95年的超声心动图和临床随访。
回复:妇产科中级考试归来!

2013.05.27 回复:妇产科中级考试归来!

1.TBS分类:见不典型鳞状细胞:鳞状上皮异常 2.最常见的尿瘘:膀胱阴道瘘 3.SUI:压力性尿失禁 4.18岁少女,有原发性痛经:用前列腺素合成酶抑制剂 5.不属于垂体性闭经:PCOS 6.雌激素水平低落:II度闭经 7.还考了两张B超图,根据子宫内膜情况,决定治疗用药,有点...
回复:请考完副主任医师的战友来晒晒题

2012.10.01 回复:请考完副主任医师的战友来晒晒题

1.宫颈外口已脱出阴道口:子宫脱垂II轻 2.子宫脱垂鉴别诊断有:宫颈延长;阴道壁肿物;粘膜下肌瘤 3.绝经2年HRT治疗:雌孕激素序贯应用 4.外阴硬化性苔藓:外阴肛周皮肤萎缩变薄 5.外阴硬化性苔藓:治疗丙酸睾酮油膏 6.外阴鳞状细胞癌:最常见的外阴癌 7.经前期综合征治疗:...
口服干扰素加注射利巴韦林治疗丙肝的2期临床试验获阳性结果

2012.06.25 口服干扰素加注射利巴韦林治疗丙肝的2期临床试验获阳性结果

2012年6月14日,赛德医药科技和阿马里诺生物科技(OTCBB:AMAR)发表声明,其产品在台湾丙型肝炎病毒感染患者上进行的剂量范围II期临床研究得到了阳性的结果。一共169名病人(1b基因型)随机地服用500或1500国际单位(IU)天然人α干扰素(IFNa)口含片或相应的空白片24周,接下来24周不服药并进行观察。所有接受IFNa和Ribavirin注射24周的病人 ...
脑深部电刺激治疗阿尔茨海默病的初步探索(上)

2018.07.06 脑深部电刺激治疗阿尔茨海默病的初步探索(上)

图 1 封面图片阿尔茨海默病(Alzheimer’s disorder, AD)是一种中枢神经系统原发性退行性疾病,全世界约有 4600 万人患有痴呆症...(NCT01608061)临床试验研究结果已在《Journal of Alzheimer’s Disease》发表。Ⅰ期临床试验已证明 DBS 能够调节功能异常的
夏日宝宝能不能吹空调?

2020.08.31 夏日宝宝能不能吹空调?

,父母可以这样调整孩子的衣物: 寒冷天气(气温在 24℃ 以下)宝宝可能需要一些衣服保暖,可以穿好贴身秋衣和尿布,然后穿一条睡裤,然后再穿上婴儿睡袋或者裹上婴儿襁褓。炎热天气(气温在 24℃ 以上)仅给宝宝一层衣服就够了,如果是小婴儿,经验就是与父母相同的环境时,在父母比较舒服的衣着情况下,多一件

2012.09.19 【免注册费】上海分子流行病学与GWAS会议国际研讨会

        分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析(GWAS)为全面系统研究复杂疾病的遗传因素掀开了新的一页,为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因,我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目,吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员,特别是广大研究生了解GWAS的研究原理和方法,学会设计GWAS的研究和分析实验结果,同时在癌症领域分享海内外研究专家们的成功经验,并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加,请有意者及时将回执返回联系邮箱。免注册费(食宿餐饮费用自理)。名额有限,报名从速!时间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆 上海市邯郸路220号,200433
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹 高歌 联系电话: 021-55664495
回执邮箱: GWAS2009@gmail.com
 BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时  间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹,高歌 (Shanghai, China);Tamara Adams (U.S.)
联系电话: 21-55664495 (Shanghai, China);336-713-7532 (U.S.)
回执邮箱: GWAS2009@gmail.com (Shanghai, China);tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factorsS. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer
 

2012.09.19 2012第二届生物能源大会

论坛5:生物质原料(II):能源作物专场500:生物能源作物的高效基因改良...507:多年生能源植物Track 5: Biomass Feedstock II: Dedicated

2017.10.20 2017 实用超声诊疗规范学习班

随着超声医学的普及,超声扫查的标准化、诊断的规范化对于超声医师的重要性日益凸显。临床医生对超声技术的适应症、检查诊断优势、对临床的决策影响等仍不足,为进一步普及和推广妇产儿科超声诊断技术,规范诊疗行为,促进学术经验交流,特举办「2017 实用超声诊疗规范学习班—妇产儿篇」,参会代表可获得市级继续教育 II 类学分 8

2009.10.16 孙燕:在既往接受治疗的晚期非小细胞肺癌(NSCLC)患者中,比较Vandetanib联合多西赛与多西他赛的III期研究(ZODIAC)

丁香园驻地通讯员报道:在2009CSCO年会上,中国医学科学院肿瘤医院孙燕院士回顾了Vandetanib I、II期研究成果。通过对全球>4500晚期NSCLC患者的研究数据表明,Vandetanib的剂量最多达到300ng,耐受良好,不良反应多为轻度,并可通过调整课题而减少。最常见的不良反应包括皮疹、腹泻等
帕金森氏病与脂肪瘤

2014.11.11 帕金森氏病与脂肪瘤

II-5)为58岁印度女性;49岁时患有左侧运动不能-强直综合征和重度抑郁;52岁时接受治疗(罗匹尼罗8mg/天,左旋多巴300mg/天)后运动症状显著改善...运动不能-强直综合征左侧重于右侧,左侧低张性体态,30岁起躯干和四肢出现多发性无痛性脂肪瘤。MRI和肌肉活检正常,脂肪瘤皮肤活检示良性血管脂肪瘤。患者II-5的哥
上一页 1 2 3 ... 44 45 46 ... 48 49 50 下一页 到第